Consensus Illumina, Inc.

Equities

ILMN

US4523271090

Delayed Nasdaq Other stock markets 03:55:28 2024-05-23 pm EDT			5-day change	1st Jan Change
105.8 ^USD	-1.45%		-7.63%	-24.07%

May. 15	Daiwa Securities Adjusts Price Target on Illumina to $120 From $133	MT
May. 14	Transcript : Illumina, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 08:30 AM

Evolution of the average Target Price on Illumina, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2c0f6288788b.a0Jfy5TWgZZiBVLGWfe0c8C1hqUxLTeziLLSMBSL2mg.IDE1_cC_scMTbwaRDrbQEp_-w5IcfGHl3_6gaWC7tQU-GhGt_onz5Qp1Zg~0fcf4fe66b7cc21f8f70db001860a853

Analyst Recommendations on Illumina, Inc.

Daiwa Securities Adjusts Price Target on Illumina to $120 From $133	May. 15	MT
Bernstein Adjusts Illumina's Price Target to $130 From $129	May. 03	MT
TD Cowen Adjusts Illumina's Price Target to $140 From $150	May. 03	MT
Baird Raises Price Target on Illumina to $128 From $125	May. 03	MT
Evercore ISI Adjusts Price Target on Illumina to $195 From $200	May. 03	MT
Leerink Adjusts Price Target on Illumina to $150 From $155	May. 03	MT
Bernstein Adjusts Price Target on Illumina to $129 From $150	Apr. 22	MT
Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept	Apr. 22	MT
HSBC Adjusts Illumina Price Target to $130 From $140	Apr. 22	MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	Apr. 16
Baptista Research Downgrades Illumina to Hold From Buy, Adjusts PT to $149.60 From $145	Apr. 16	MT
Leerink Partners Adjusts Illumina's Price Target to $155 From $170	Apr. 12	MT
RBC Cuts Price Target on Illumina to $253 From $258, Keeps Outperform Rating	Apr. 08	MT
OTR Global Downgrades Illumina to Mixed From Positive	Mar. 20	MT
Exclusive-Icahn drops Illumina board challenge threat, sources say	Mar. 12	RE
UBS Adjusts Illumina Price Target to $145 From $111, Maintains Neutral Rating	Feb. 09	MT
TD Cowen Adjusts Price Target on Illumina to $150 From $144, Maintains Market Perform Rating	Feb. 09	MT
This time it's for real	Feb. 09
Barclays Adjusts Price Target on Illumina to $85 From $80, Maintains Underweight Rating	Feb. 09	MT
Citigroup Adjusts Price Target on Illumina to $145 From $120, Maintains Neutral Rating	Feb. 09	MT
Stifel Adjusts Price Target on Illumina to $160 From $125, Maintains Buy Rating	Feb. 09	MT
Baird Adjusts Price Target on Illumina to $146 From $144, Maintains Neutral Rating	Feb. 09	MT
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber...	Feb. 09
ANALYST RECOMMENDATIONS : Dollar Tree, Intel, Snap, Hershey, Fresnillo...	Jan. 29
Barclays Adjusts Price Target on Illumina to $80 From $50, Maintains Underweight Rating	Jan. 25	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

107.4 USD

Average target price

155.5 USD

Spread / Average Target

+44.81%

High Price Target

253 USD

Spread / Highest target

+135.59%

Low Price Target

100 USD

Spread / Lowest Target

-6.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Illumina, Inc.

Daiwa Securities
Bernstein
TD Cowen
Baird
Evercore ISI
Leerink Partners
HSBC
Baptista Research
RBC Capital Markets
OTR Global
UBS
Barclays
Citigroup
Stifel Nicolaus
Scotiabank
Stephens Inc.
BofA Securities
Canaccord Genuity
Piper Sandler
JPMorgan Chase
Credit Suisse
SVB Securities LLC
Argus
Morgan Stanley
Cowen
SVB Leerink
BTIG
Wells Fargo Securities
Atlantic Equities

Ratings for Illumina, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar